Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on July 02, 2020, 04:46:47 pm
-
For people with opioid use disorder (OUD) and hepatitis C virus (HCV), treating the two conditions at the same time is associated with manifold benefits, Healio reports.
Elana Rosenthal, MD, an assistant professor at the University of Maryland School of Medicine Institute of Human Virology, and colleagues conducted a prospective, open-label observational study called ANCHOR that included 100 people with OUD and HCV who engaged in ongoing injection drug use.
The participants, who were recruited for the study at a harm reduction drop-in center in Washington, DC, were offered buprenorphine, a form of medication-assisted treatment (MAT) to treat OUD, as well as 12 weeks of Epclusa (sofosbuvir/velpatasvir) for HCV.
For more...
https://www.hepmag.com/article/reasons-treat-opioid-use-disorder-hep-c-together-abound